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Abstract
Coeliac disease (CD) is an autoimmune disorder triggered by gluten proteins (gliadin) that involves innate and adaptive
immunity. In this study, we hypothesise that the administration of Bifidobacterium longum CECT 7347, previously selected
for reducing gliadin immunotoxic effects in vitro, could exert protective effects in an animal model of gliadin-induced
enteropathy. The effects of this bacterium were evaluated in newborn rats fed gliadin alone or sensitised with interferon
(IFN)-c and fed gliadin. Jejunal tissue sections were collected for histological, NFkB mRNA expression and cytokine
production analyses. Leukocyte populations and T-cell subsets were analysed in peripheral blood samples. The possible
translocation of the bacterium to different organs was determined by plate counting and the composition of the colonic
microbiota was quantified by real-time PCR. Feeding gliadin alone reduced enterocyte height and peripheral CD4+ cells, but
increased CD4+/Foxp3+ T and CD8+ cells, while the simultaneous administration of B. longum CECT 7347 exerted opposite
effects. Animals sensitised with IFN-c and fed gliadin showed high cellular infiltration, reduced villi width and enterocyte
height. Sensitised animals also exhibited increased NFkB mRNA expression and TNF-a production in tissue sections. B.
longum CECT 7347 administration increased NFkB expression and IL-10, but reduced TNF-a, production in the enteropathy
model. In sensitised gliadin-fed animals, CD4+, CD4+/Foxp3+ and CD8+ T cells increased, whereas the administration of B.
longum CECT 7347 reduced CD4+ and CD4+/Foxp3+ cell populations and increased CD8+ T cell populations. The
bifidobacterial strain administered represented between 75–95% of the total bifidobacteria isolated from all treated groups,
and translocation to organs was not detected. These findings indicate that B. longum attenuates the production of
inflammatory cytokines and the CD4+ T-cell mediated immune response in an animal model of gliadin-induced
enteropathy.
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Introduction
Coeliac disease (CD) is an autoimmune enteropathy triggered
by cereal gluten proteins (gliadin) in genetically predisposed
individuals [1]. In CD patients, peptides resulting from incomplete
protein hydrolysis by digestive enzymes cause a deregulated
immune response and inflammation. The degree of intestinal
inflammation can vary from intraepithelial lymphocytosis to severe
infiltration of mononuclear cells in the lamina propria, causing
villous atrophy and crypt cell hyperplasia in the small intestine [2].
Several attempts have been made to develop animal models that
reproduce CD pathogenesis, including the immune response, the
mucosal lesions and the symptoms [3–5]. The intragastric
administration of gliadin to inbred rats after weaning [4] or to
immunocompetent mice at 10 days of age failed to reproduce the
damage of the intestinal mucosa [6]. Human leukocyte antigen
(HLA)-DQ8/HCD4 or single HLA-DQ8 transgenic mice sensi-
tised with gluten developed an immune response to gliadin that
involved both the adaptive and innate immune system [7,8] and
dependent changes in gut neuromuscular and epithelial secretory
function [8], but did not develop a gluten-dependent enteropathy.
Nevertheless, repeated oral administration of gliadin to rats,
previously sensitised with interferon gamma (IFN-c) immediately
after birth, caused mucosal lesions characterised by shortening of
jejunal villi, crypt hyperplasia, and increased cellular infiltration,
including CD8ab+ and CD4+ T lymphocytes [9]. Activation of
CD4+ T-helper 1 (Th1) cells that produce IFN-c and intraep-
ithelial CD8+ lymphocytes are also responsible for the cytotoxic
effects on intestinal epithelium, which in turn could increase
passage of gliadin antigens to the lamina propria and further
activate the CD4+ Th1 cell response [10,11]. Thus, this model
reproduces a CD4+ T cell mediated enteropathy, defined as
hyperplasic-infiltrative (type II), similar to that described in CD
patients [9]. Undoubtedly, further refinement of the available
animal model of CD is desirable, but it is considered appropriate
to initially explore pathogenic mechanisms and potential pharma-
ceutical or nutritional interventions [9].
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constitutes one of immunosuppressive mechanisms that contribute
to intestinal tolerance and prevention of autoimmunity. In
particular, natural self-antigen-reactive CD4+CD25+ cells ac-
quired Foxp3 expression, a key marker of the development of
regulatory activity, in the thymus and then enter peripheral tissues,
where they can suppress the activation of other self-reactive T cells
contributing to immune tolerance. These Tregs
(CD4+CD25+Foxp3+) are particularly increased in the mucosa
and peripheral blood of active CD patients as a consequence of the
activation of a regulatory response to counteract the inflammation
caused by gluten [12,13], but their role in animal models of CD
has not been studied so far.
In recent years, innate immunity and early interactions of
gliadin-derived peptides with intestinal epithelial cells have also
been considered critical in the development of the disease. Some
gluten peptides can mediate an innate-immune response that
involves induction of interleukine (IL)-15 production by epithelial
and dendritic cells. IL-15 induces up-regulation of the non-MHC
class I receptor NKG2D on intraepithelial lymphocytes (IELs),
and its ligand MICA on epithelial cells, that interact and activate
cytolytic function on enterocytes [14]. The activation of the NFkB
pathway in intestinal epithelial cells also mediates the production
of other inflammatory cytokines, such as the tumour necrosis
factor (TNF)-a, which facilitates the interaction of IELs and
intestinal epithelial cells promoting tissue inflammation [15].
In germ-free rat pups, colonisation by the whole microbiota has
similar effects as administration of gliadin on IEL subpopulations,
suggesting that both factors activate common immunological
responses that may influence CD development [4]. Human studies
also report that CD is characterised by imbalances in the
composition of the microbiota and, particularly, reduced numbers
of total bifidobacteria and B. longum [16]. In vitro studies have
demonstrated that the presence of B. longum CECT 7347 during
the intestinal digestion of gliadin leads to the generation of
different peptide sequences and reduces their toxic and inflam-
matory effects on intestinal epithelial cells [17]. In addition, B.
longum CECT 7347 has been shown in vitro to counteract the
inflammatory response induced by the altered faecal microbiota of
CD patients in peripheral blood mononuclear cells [18]. Yet, the
possible in vivo effects of this bifidobacterial strain on CD have not
been evaluated.
In the light of the evidence available, in this study we
hypothesise that the administration of B. longum CECT 7347,
with immunoregulatory properties and ability to attenuate in vitro
gliadin toxicity on epithelial cells, could exert protective effects in a
model of gliadin-induced enteropathy in weaning rats.
Materials and Methods
Bacterial strain and culture conditions
Bifidobacterium longum CECT 7347 was isolated from faeces of
healthy infants as described elsewhere [18]. The bacterial cultures
were grown in Man-Rogosa-Sharpe agar and broth (Scharlau,
Barcelona, Spain) supplemented with 0.05% (w/v) cysteine (MRS-
C; Sigma-Aldrich, St. Louis, USA), and kept at 37uC in anaerobic
conditions (AnaeroGen, Oxoid, Basingstoke, UK) for 24 h. For
animal studies, a pure culture of the strain was grown overnight
and used to inoculate fresh MRS-C broth for 22 h. Cells were
harvested by centrifugation (6,0006g for 15 min) at stationary
growth phase, washed twice in phosphate buffered saline (PBS,
130 mM sodium chloride and 10 mM sodium phosphate,
pH 7.4), and re-suspended in 10% (w/v) hypoallergenic milk-
based formula (Nutramigen, Mead Johnson B.V., Nijmegen,
Netherlands). Aliquots of these cell suspensions were frozen in
liquid nitrogen and stored at 280uC until used. The number of
live cells after freezing and thawing was determined by plate
counting on MRS-C agar after 48 h of incubation, and were
expressed as colony-forming units (CFU) per mL. More than 90%
of cells were alive upon thawing and no significant differences were
found during storage time (4 months). One fresh aliquot was
thawed for every new experiment to avoid variability in bacterial
cell viability between experiments.
Animals and experimental design
Animal experiments were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of University of Valencia (SCSIE, University
of Valencia, Spain) and the protocol was approved by its Ethic
Committee. Experimental animals were female, weaning Wistar
rats, provided by the SCSIE. The adult females were date-mated,
and fed ad libitum with a standard diet (Harlan Bioproducts,
Indianapolis, USA). Shortly after spontaneous birth, animals were
randomly distributed into seven different groups (n=6 per group):
1) artificially reared (AR) with the hypoallergenic milk-based
formula; 2) AR and fed B. longum CECT 7347; 3) AR and fed
gliadin-derived peptides (GP); 4) AR and fed GP and B. longum
CECT 7347; 5) AR sensitised with 1,000 U IFN-c administered
intraperitoneally immediately after birth; 6) AR sensitised with
1,000 U IFN-c administered intraperitoneally immediately after
birth and fed GP; 7) AR sensitised with IFN-c and fed GP and B.
longum CECT 7347.
Newborn animals were hand-fed (100 mL) using a micropipette
every 4 hours (4–5 times a day) until the age of 10 days. They were
fed with the hypoallergenic milk-based formula for newborns,
composed of: 19 g proteins; 34 g fats; 75 g carbohydrates;
680 Kcal; 260 mOsm per L. The bacterium was administered at
a concentration of 6.0610
7–8.2610
8 CFU/day, as determined by
plate counting on MRS-C agar, in a single dose during the 10
days. To obtain the GP, a commercially available extract of gliadin
(Sigma-Aldrich, St. Louis, USA) was submitted to in vitro digestion
and then dialysed using a 15 kDa cut-off membrane [17].
Weaning rats were fed 50 mg gliadin/day in a single dose during
the 10 days, and, finally, they received a provocative dose of
gliadin 100 mg ,2 hours before sacrifice.
Changes in body weight were monitored every two days. After
treatment, rats were anaesthetised (isofluran) and killed by
exsanguination. Whole blood samples were preserved in EDTA-
treated tubes to prevent coagulation (at room temperature) for
leukocyte analyses. Sections (1 cm) of the proximal jejunum were
immersed in RNA later buffer (Qiagen, USA) or Krebs’s buffer and
kept at 280uC for gene expression and cytokine analyses. Liver,
spleen and colon content samples were also collected in PBS and
immediately used for microbiological analyses by plate culturing.
Histologic and morphometric evaluation
Jejunal tissue sections (1 cm) were fixed in formaldehyde 10%
(p/v) and then sections of 5 mm were stained with haematoxylin-
eosin staining. The samples were analysed with a Nikon Eclipse
90i microscope equipped with a Nikon DS-5Mc digital camera.
Photos were analysed with the Nis Elements software (Nikon
Instruments Inc., Melville, USA). The parameters analysed
included, villi width and length and number of infiltrated cells in
the lamina propria, because their changes characterized the
histologic lesions of this enteropathy, and the number and height
of enterocytes that provide an indication of the disorganization of
the cellular epithelial layer.
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The morphological identification of immune cells was conduct-
ed by the May-Gru ¨nwald Giemsa’s staining procedure. Aliquots
(25 mL) of blood samples were extended on glass slides and were
allowed to air-dry. The samples were covered with May-
Gru ¨nwald’s solution (Sigma-Aldrich, St. Louis, USA) for 3 min-
utes, and afterwards an equal volume of phosphate buffered
distilled water (PBDW, pH 7) was added and incubated for 3
additional minutes. The preparations were gently rinsed with
PBDW, and then covered with a dilution (1:20, v/v) of the Giemsa
stain-modified solution in PBDW for 12 minutes. Finally, the
samples were washed with PBDW, air-dried and analysed using an
Olympus BX51 microscope (Madrid, Spain).
Lymphocyte phenotyping
Aliquots (100 mL) of peripheral blood were mixed with the
following fluorochrome-conjugated antibodies: Anti-rat CD45,
CD4, CD8 and Foxp3 (eBiosciences, Hattfield, UK). Then
samples were prepared for flow cytometry analysis with the
Immunoprep kit (Beckman Coulter, USA) according to the
manufacturer’s instructions, and further analysed on a Modular
Flow Cytometer Cell Sorter (MoFlo Sorter, Dakocytomation,
USA).
Real-time reverse transcription-polymerase chain
reaction (RT-qPCR)
Total RNA was extracted from tissue samples with the RNeasy
mini kit (Qiagen) according to the manufacturer’s instructions.
One microgram of total RNA was converted to double-stranded
cDNA using AMV Reverse Transcriptase (Promega, Madison,
USA). PCR was performed with primers designed for the
following Rattus norvegicus genes: NFkB (forward 59- CTT CTC
GGA GTC CCT CAC TG-39, reverse 59- CCA ATA GCA GCT
GGA AAA GC-39) and b-actin (forward 59- CTC TTC CAG
CCT TCC TTC CT-39; reverse 59- TAG AGC CAC CAA TCC
ACA CA-39), the latter used as a housekeeping gene. The PCR
mix (20 mL reaction volume) consisted of 7.5 mL SYBR Green I
master mix, 1.3 mmol/L primers, and 2.5 mL cDNA. PCR
reactions were performed in triplicate in a LightCyclerH 480
(Roche) system with the following conditions: 1 cycle at 95uC for
5 min, 35 cycles at 60uC for 20 s and 72uC for 45 s. The relative
mRNA expression of the tested gene relative to b-actin expression
was calculated using the 2
2DDCp method [19]. Samples of each
animal tissue were measured in duplicate and gene expression was
expressed as fold-change.
Cytokine protein assay
Jejunal tissue sections (1 cm) were kept in Krebs’s buffer (1 ml)
supplemented with protease inhibitors (Roche) until analysis.
Tumour necrosis factor-a (TNF-a, Diaclone, Besanc ¸on, France),
and interleukine (IL)-10 (Abcam, Cambridge, UK) were deter-
mined by ELISAs according to the manufacturer’s instructions.
Prior to cytokine determination, tissue samples were homogenised
in cell lysis buffer using a TissueRuptor (Qiagen). Then, samples
were centrifuged (10006g, 15 min) to get clear supernatants for
cytokine determination. The results of the ELISA assay are
expressed as pico-grams per gram of tissue (pg/g).
Microbiological analyses
Aliquots (50 mg) of different biologic samples (colon content,
mesenteric lymph nodes [MLN], spleen and liver) were diluted (1/
9) in PBS and decimal dilutions were plated on MRS-C agar
supplemented with mupirocin (80 mg/L) (Sigma-Aldrich) and
acetic acid (1 ml/L) to increase the selectivity of the medium for
bifidobacteria. Counts were performed on the highest dilution
plates and were expressed as colony forming units (CFU) per gram
of faeces. Isolated colonies (8–10) from colon samples were also
checked by RAPD PCR analysis to confirm whether the DNA
profile of the isolates corresponded with the DNA profile of a pure
culture of the administered strain B. longum CECT 7347. The
random primer 1254 (59-CCG CAG CCA A-39) was used for
RAPID-PCR analysis as previously described [20]. The RAPD-
PCR products were visualised on a 1.5% w/v agarose gel after
staining with ethidium bromide.
The composition of the microbiota was also analysed by real-
time PCR. Samples of colon content were collected, diluted 1:10
(w/v) in PBS (pH 7.2) and homogenised thoroughly by agitation in
a vortex. Aliquots were used for DNA extraction using the
QIAamp DNA stool Mini kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. Genus-, group- and
species-specific primers were used as described previously to
quantify the different bacterial groups of the intestinal microbiota
[21,22]. Briefly, PCR amplification and detection were performed
with an ABI PRISM 7000-PCR sequence detection system
(Applied Biosystems, UK). Each reaction mixture (15 ml) consisted
of 7.5 ml of SYBRH Green PCR Master Mix (Roche), 3.5 mlo f
sterile water, 0.75 ml of each of the specific primers at a
concentration of 10 mM, and 2.5 ml of template DNA. 16 rRNA
gene copy numbers of each bacterial group or species were
calculated by comparing the Ct values obtained with those from a
standard curve [23]. Standard curves were generated from serial
dilutions of a known copy number of the target gene cloned into a
plasmid vector. For each reference strain the 16S rRNA gene was
cloned into a pGEM-T Easy Vector System (Promega). An E. coli
strain was transformed with the recombinant plasmids and
plasmid DNA was extracted from E. coli by the miniprep method
[24]. Six non-zero standard concentrations were used to construct
the standard curves for each reference strain representing a species
or a group, and the plasmid DNA concentrations ranged from 10
4
to 10
10 copies of DNA per reaction. Standard curves were
constructed by plotting the Ct values against the logarithm of their
initial template copy number. DNA concentration was measured
using a NanoDropH and the corresponding copy number was
calculated [25]. The following reference strains were used as
standards: Bifidobacterium longum subsp. longum CECT 4503,
Bacteroides fragilis DSMZ 2451; Clostridium coccoides DSMZ 933; C.
leptum DSMZ 935; Lactobacillus casei ATCC 393; and E. coli CECT
4558.
Statistical analyses
Statistical analyses were performed using SPSS v.15 software
(SPSS Inc., Chicago, IL, USA). For normally distributed data
ANOVA and the Student t test were applied and, for non-
normally distributed data, the Mann-Whitney U test was used.
Statistical significance was established at P,0.05 for all compar-
isons.
Results
Body weight and morphometric analyses of jejunal
sections
Significant (P.0.05) differences in body weight were not
detected among the different experimental animal groups (data
not shown). The animals sensitised with interferon (IFN)-c and fed
gliadin were the only ones that presented signs of diarrhoea. The
animal group that was diagnosed with diarrhoea had faecal spots
around the anal area and the colon contents recovered after the
B. longum CECT 7347 in an Enteropathy Animal Model
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tissue sections revealed that animals fed with gliadin alone did not
exhibit significant alterations compared to controls, except for
decreased (P=0.014) enterocyte height (Table 1), but this
alteration was restored by simultaneous administration of B.
longum CECT 7347. In animals sensitised with interferon (IFN)-c
and fed gliadin, there was a significant decrease in villi width
(P=0.048) and enterocyte height (P=0.033) and an increase in
enterocyte numbers (P=0.001) in the apical part of jejunal
sections and also higher (P=0.001) infiltration of cells in the
lamina propria (Figure 1) compared to the controls. However,
these changes were not observed in animals only sensitized with
IFN-c but not fed gliadin. B. longum CECT 7347 administration
increased villi width (P=0.004) and enterocyte height (P=0.005),
partially restoring the alterations detected in animals sensitised
with IFN-c and fed gliadin but did not decrease the cellular
infiltration observed in the IFN/gliadin group. Feeding of B.
longum CECT 7347 alone or together with gliadin increased
(P=0.016 and P=0.020, respectively) villi length when compared
to control animals.
NFkB mRNA expression analysis
Gliadin feeding significantly (P=0.013) reduced NFkB mRNA
expression, while the simultaneous administration of B. longum
CECT 7347 restored its levels, reaching similar values as those of
controls (Figure 2). In animals sensitised with IFN-c and fed
gliadin, NFkB expression was markedly increased (P,0.001) and
the simultaneous administration of B. longum CECT 7347
produced even higher NFkB( P=0.045) gene expression. Feeding
of B. longum CECT 7347 alone to weaning animals did not alter
the basal expression of this inflammatory marker, indicating that
the intestinal inflammatory milieu and the simultaneous presence
of other stimuli modify the immune effects of this bacterial strain.
Sensitisation with IFN-c immediately after birth did not exert a
significant effect in comparison with controls.
Cytokine production
The cytokine concentrations in jejunal tissue sections from
different experimental animal groups quantified by ELISA are
shown in Figure 3. In tissue samples from animals fed either
gliadin or B. longum CECT 7347 the concentration of the
inflammatory cytokine TNFa was not increased, but that of the
anti-inflammatory cytokine IL-10 (P=0.003, P=0.006, respec-
tively) did increase in comparison with controls. The simultaneous
administration of both gliadin and B. longum CECT 7347 caused a
significant increase in TNFa and IL-10 production, in comparison
with the control (P=0.012 and P=0.028, respectively) and with
the administration of either gliadin (P,0.001 and P=0.017,
respectively) or B. longum CECT 7347 (P=0.029 and P=0.001,
respectively) alone. In animals sensitised with IFN-c and fed
gliadin, TNFa concentrations were significantly (P=0.007)
increased and, to a lesser extent, also those of IL-10 (P=0.008)
in comparison with control animals. This effect could be only
attributed to the administration of gliadin in IFN-c sensitised
animals because animals only sensitized with IFN-c but not fed
with gliadin did not exhibit significant increases in cytokine
production. The administration of B. longum CECT 7347 to the
enteropathy model significantly reduced TNFa (P=0.003) and
increased IL-10 (P,0.001) production, indicating its ability to
counteract the inflammatory response in the intestinal mucosa.
Leukocyte count and lymphocyte phenotyping
The alterations in peripheral leukocyte populations in different
animalgroupsareshowninTable2.Gliadin administration did not
cause significant alterations in the lymphocyte population compared
to controls, except for an increase in eosinophils (P=0.048). This
alteration was restored by simultaneous administration of B. longum
CECT 7347 (P=0.048). Sensitization of animals with IFN-c alone
didnotcausesignificantchangesinleukocytepopulation,butfeeding
gliadin to animals sensitised with IFN-c decreased lymphocyte
populations significantly (P=0.028) in comparison to non-sensitised
animals that had beenfed gliadin. In contrast, monocyte populations
significantly increased in sensitized and gliadin-fed animals
(P=0.039) and also in those simultaneously fed B. longum CECT
7347 (P=0.005) in comparison to controls. The administration of
the bifidobacterial strain alone did not significantly modify the
leukocyte populations in comparison to controls.
In rats, leukocyte counts have been reported to be highly variable
in the range from 6,000 to 18,000 leukocytes/ml [26], which is in
agreement with the values found in our experimental animal
groups. The lymphocyte population was identified with the
lymphocyte marker CD45 and further T-cell phenotyping analyses
were done within this population (Figure 4). Feeding gliadin
significantly reduced CD4+ lymphocyte numbers (P=0.003)
compared to controls, whereas Foxp3+ T cell numbers increased
(P,0.001). The administration of B. longum CECT 7347 together
with gliadin exerted the opposite effects in all T-lymphocyte
subpopulations, increasing CD4+ cells (P=0.010) and reducing
Table 1. Morphometric evaluation of jejunal sections.
Treatmentl Control Gliadin B. longum Gliadin/B. longum IFN-c IFN-c/Gliadin
IFN-c/Gliadin/B.
longum
Villi width (mm) 46.1567.56
a 42.6566.39 57.1066.23 57.5368.36 48.5766.35 38.2768.46
ab 50.4662.61
ab
length (mm) 193.37615.53
c, d 156.68629.74 255.83631.57
d 247.44651.74
c 187.68626.10 165.88636.62 196.74614.00
Infiltrated
cells
1
7.7561.25
e,f,g 8.8061.64 8.1260.80 10.2461.10
e 6.8562.12
h 11.2560.96
f, h 10.5261.57
g
Enterocytes height (mm) 7.0461.66
i,j 4.2961.24
i, k 8.3261.58 7.7161.01
k 7.6861.92 4.7961.03
j, l 7.2260.96
l
counts
2 4.8060.80
m,n 6.8360.75 5.0960.62 6.7561.22 5.126097 8.2060.80
m 8.0160.35
n
The results are expressed as mean 6 standard deviation of 20 independent microscopic fields of each animal (n=6).
a-lSuperscript letters in the same row indicate statistically significant (P,0.05) differences between the pair of samples that has the same letter as determined applying
the Student t test (*).
1Number of cells in a surface of 20 mm
2 at the lamina propria;
2Number of enterocytes a long 20 mm at the luminal side of the intestinal epithelia.
* P values: a, 0.050; b, 0.004; c, 0.020; d, 0.016; e, 0.004; f, 0.001; g, 0.007; h, 0.043; i, 0.014; j, 0.033; k, 0.005; l, 0.005; m, 0.001; n, 0.001.
doi:10.1371/journal.pone.0030744.t001
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with IFN-c exhibited significantly (P=0.041) increases in CD4+
cells, but not in CD8+ and CD4+Foxp3 cells. In animals sensitised
withIFN-c andfedgliadin,therewasa muchmore markedincrease
in all T-lymphocyte subpopulations compared to controls. In this
model, the administration of B. longum CECT 7347 significantly
reduced CD4+ (P=0.032) and Foxp3+ T( P=0.038) cell popula-
tions, but increased those of CD8+ cells (P=0.022). The
administration of B. longum CECT 7347 alone did not significantly
affect any of the T cell lymphocyte populations analysed.
Bacterial translocation and microbiota composition
Translocation of Bifidobacterium spp. to liver, spleen and MLN
was not detected by plate counting in any of the treated animal
groups. RAPD analyses of colonies isolated from selective media
for bifidobacteria present in colon samples indicated that the strain
administered represented between 75–95% of the total bifidobac-
teria. The quantitative analyses of specific bacterial groups by real
time-PCR also indicated that the administration of the bifido-
bacterial strain contributed to an increase in the total gene copies
of this bacterial group by at least one logarithmic unit (Table 3).
Neither feeding gliadin alone nor sensitization with IFN-c alone
significantly modified the composition of the microbiota in
comparison with controls. In animals sensitised with IFN-c and
fed gliadin, significantly higher gene copy numbers of the
Bacteroides fragilis group were detected in comparison with controls
(P=0.030) and with rats fed gliadin (P=0.020) and gliadin plus B.
longum CECT 7347 (P=0.049), and with those sensitized with
IFN-c (P=0.025). The administration of B. longum CECT 7347
did not restore microbiota alterations in the enteropathy model
and only contributed to increasing total Bifidobacterium gene copy
numbers.
Discussion
This study reports for the first time the effects of feeding a
bifidobacterial strain (B. longum CECT 7347) at an early postnatal
period on the intestinal mucosal architecture and markers of
innate and adaptive immunity in an experimental animal model of
gliadin-induced enteropathy.
In previous studies, gliadin administration to inbred rats after
weaning [4] or adult mice [6] failed to reproduce the enteropathy,
probably due to immunocompetence of the experimental animals
and lack of gliadin access beyond the epithelial cell layer.
Moreover, feeding gliadin even during the early neonatal period
was insufficient to cause mucosal damage and significant
alterations in epithelium architecture in agreement with our study
[4,27]. Sensitisation of animals with IFN-c appeared to be
necessary to cause mucosal damage and immunological changes
resembling those observed in human CD [9]. IFN-c administra-
tion to weaning animals increases macromolecular transport
across Peyer’s patches [28], and macrophage priming [29] that
favours the full establishment of a jejunal mucosal reaction and the
instauration of the enteropathy [9]. However sensitisation with
IFN-c alone did not caused histological alterations in our study, in
accordance with previous reports [9]. Thus, the animal model
used in the present study approaches an intermediate state
between proliferative and destructive phases of CD that, in
patients, ultimately lead to complete villous atrophy and disruption
of intestinal epithelium integrity, which are major characteristics of
fully developed CD [2,30]. B. longum CECT 7347 administration
to gliadin-fed animals, sensitised with IFN-c, partially reduced
some of the alterations in jejunal architecture caused by the
triggers of the disease, which could theoretically contribute to
improving the gut barrier function and preventing gliadin
translocation to the submucosa. Similarly, administration of
Lactobacillus casei ATCC 9595 restored the intestinal damage
caused by gliadin in HLA-DQ8 transgenic mice treated with
indomethacin [27].
In CD patients, gliadin acts as potent inducer of inflammatory
gene expression and cytokine production, including TNFa and
NFkB activation [31–33]. In this study, NFkB expression (mRNA)
was increased in animals sensitised with IFN-c and fed gliadin, in
agreement with the NFkB activation found in the intestinal
mucosa of CD patients [32]. NFkB activation has been identified
as the mechanism by which gliadin mediates TNFa production in
enterocytes [17] and human monocytes [33]. Accordingly, TNFa
production was also significantly increased in animals sensitised
Figure 1. Histology of jejunal tissue sections of different
experimental rat groups, stained with hematoxylin-eosin
showing the different degree of cellular infiltration in the
lamina propria of animals sensitized or not with IFN-c and fed
gliadins and B. longum CECT 7347. Scale bar, 100 mm.
doi:10.1371/journal.pone.0030744.g001
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alone neither induced NFkB expression nor TNFa production in
comparison with controls. It is possible that gliadin administered
alone stimulates a regulatory response reflected in the down-
regulation of NFkB mRNA expression and the increased IL-10
production leading to tolerance in these animals, which are not
genetically predisposed to the disease. In fact, previous authors
also demonstrated that IFN-c administered intraperitoneally was
necessary to induce the disease together with oral administration
of gliadin [9]. In contrast, the simultaneous administration of B.
longum CECT 7347 and gliadin increased NFkB mRNA
expression and cytokine production in comparison with the group
only fed gliadin. This could be due to additional interactions of
bacterial components with Toll-like receptors (TLRs) that upon-
ligand binding can also activate the NFkB pathway and cytokine
production. Therefore, the results indicate that this bacterial strain
caused certain immune activation in the simultaneous presence of
gliadin; however, these effects were not significant in comparison
with the control group except for cytokine production and were
not translated in other pathologic signs. Notably, the administra-
tion of B. longum CECT 7347 to animals sensitised with IFN-c and
fed gliadin reduced TNFa production and increased IL-10
production and NFkB expression, triggering an anti-inflamma-
tory and regulatory response. Interestingly, the two treatments
IFN-c sensitization plus gliadin feeding and IFN-c sensitization
plus gliadin and B. longum feeding activated NFkB mRNA
expression, but the final effects on cytokine production markedly
differed. The effects on these inflammatory markers on our
enteropathy animal model are in agreement with the inflamma-
tory role of gliadins in CD patients and enterocytes previously
reported [15,32]. However, an increase in NFkB mRNA
expression does not always lead to an inflammatory response
because this pathway is regulated at different stages and by
diverse mechanisms controlling, for instance, the ubiquitination
of the inhibitor IkB, which promotes the translocation of the
heterodimer p50/p65 to the nucleus and the final induction of
inflammatory cytokines such as TNFa [34]. In this context, it has
been reported that some commensal bacteria can induce
transient activation or inhibition of the NFkB signalling pathway
at different steps that contribute to attenuating and regulating the
pro-inflammatory responses. For example B. thetaiotaomicron acts
downstream NFkB activation by promoting nuclear export of
Figure 2. Expression (mRNA) of nuclear factor kappa B (NFkB) in jejunal sections of rats after different treatments. The results are
expressed as mean 6 standard deviation (n=6). *Indicates statistically significant (P,0.05) differences relative to the controls; bars indicate
significant differences between the specific pair comparisons as determined by applying the Student t test.
doi:10.1371/journal.pone.0030744.g002
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commensal bacteria block NFkB at more proximal steps,
inhibiting ubiquitination and proteolytic inactivation of the
endogenous NF-kB inhibitor IkB [36]. Therefore, it is possible
that the B. longum strain used in this study only causes a transient
activation of NF-kB mRNA expression without enhancing the
final production of inflammatory mediators such as TNF-a in the
enteropathy animal model.
Figure 3. Tumour necrosis factor (TNF)-a and interleukine (IL)-10 production in jejunal tissue sections of rats after different
treatments. The results are expressed as mean 6 standard deviation (n=6). *Indicates statistically significant (P,0.05) differences compared to the
controls; bars indicate significant differences between the specific pair comparisons as determined by applying the Student t test.
doi:10.1371/journal.pone.0030744.g003
Table 2. Leukocyte percentages (%) in peripheral blood of different rat experimental groups.
Cells Treatment
Control Gliadin B. longum Gliadin/B. longum IFN-c IFN-c/Gliadin
IFN-c/Gliadin/B.
longum
Neutrophil 17.163.8 18.664.9 20.263.9 19.161.8 17.262.3 22.264.0 18.565.5
Lymphocyte 73.767.1 78.065.6
a 72.566.8 73.4611.1 73.361.9 66.865.4
a 69.264.8
Monocyte 3.360.6
b, c 3.660.9 2.961.1 3.461.2 4.161.3 6.061.9
b 6.561.5
c
Eosinophilo 4.360.7
d 5.360.6
d,e 5.661.3 2.761.4
e 3.361.7 4.261.2 4.961.1
Basophil 1.360.4 1.660.9 1.161.0 1.160.2 2.161.1 0.860.6 0.760.5
The results are expressed as mean 6 SD (n=6).
a-eSuperscript letters in a same row indicate statistically (P,0.05) significant differences between the pair of samples that has the same letter as determined applying the
Student t test (*).
* P values: a, 0.028; b, 0.039; c, 0.005; d, 0.048; e, 0.048.
doi:10.1371/journal.pone.0030744.t002
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30744Table 3. Microbiota composition of colon content determined by real time PCR and expressed as log copy number of 16S rDNA
gene per gram of faeces.
Bacterial group Control Gliadin Gliadin/B. longum B. longum IFN-c IFN-c/gliadin
IFN-c/gliadin/B.
longum
C. coccoides group 8.99
a 8.18
b 6.75
c 8.37 7.06
d 10.74 10.72
a, b, c, d
(5.12–9.80) (4.30–10.38) (4.53–9.10) (5.74–11.14) (6.94–7.18) (4.50–11.1) (8.90–11.09)
C. leptum group 5.34 5.28 5.33 5.58 7.16 7.84 8.45
(5.15–6.65) (4.04–7.57) (4.62–5.97) (4.40–9.33) (6.07–8.29) (5.09–9.13) (4.53–9.12)
Lactobacillus group 9.60 9.76 10.01 10.09 9.24 9.47 9.65
(8.03–10.19) (9.17–9.98) (9.14–10.51) (9.69–10.39) (8.14–11.10) (8.50–10.46) (8.40–10.32)
Enterobacteriaceae 9.04 9.43 9.24 9.33 8.27 8.89 9.37
(8.91–9.84) (9.12–9.77) (8.85–9.52) (9.15–9.42) (6.58–10.70) (7.90–9.52) (7.45–9.91)
Bifidobacterium 6.77
e, f, g 6.17
h, i 8.13
e, j 8.26
f, k 7.81
l 7.00
h, m 10.18
g, i, j, k, l, m
(5.89–8.45) (3.00–9.66) (7.26–8.61) (6.97–10.56) (6.97–9.08) (4.83–10.57) (9.29–10.59)
B. fragilis group 7.44
n 7.13
o, p 5.64
q, r 7.49 7.15
s 11.07
n, o, q, s 10.80
p, r
(3.76–8.69) (5.93–8.49) (2.06–8.10) (3.30–11.41) (3.60–10.38) (9.99–11.3) (7.09–11.39)
Data are expressed as median (range of values) (n=6).
a-nSuperscript letters indicate statistically significant (P,0.05) differences between the pair of samples that has the same letter by applying the Mann-Whitney U test.
doi:10.1371/journal.pone.0030744.t003
Figure 4. Phenotyping of lymphocyte populations in peripheral blood of rats after different treatments. The results are expressed as
mean 6 standard deviation (n=6). *Indicates statistically significant (P,0.05) differences relative to the controls; bars indicate significant differences
between the specific pair comparisons as determined by applying the Student t test.
doi:10.1371/journal.pone.0030744.g004
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the immunomodulatory properties of B. longum CECT 7347 and L.
casei ATCC 9595, since this latter strain was unable to rescue IL-
10 production in the enteropathy model of HLA-DQ8 transgenic
mice [27]. IL-10 production was also stimulated by the
administration of B. longum CECT 7347 alone in control mice
but not that of TNF-a, which is an additional indication of the
anti-inflammatory properties of this strain also in the absence of
other stimuli such as gliadin or an inflammatory condition. IL-10
seems to be indispensable for the induction of oral tolerance to
dietary antigens, the inhibition of chemokine production and the
antigen-presenting capacity of monocytes and macrophages, and
induction of the production of soluble antagonists of pro-
inflammatory cytokines such as IL-1 and TNFa [37].
Leukocyte counts and phenotyping analyses of T-cell subsets in
peripheral blood support that IFN-c sensitisation of weaning
animals is effective in stimulating a T cell-mediated response to
orally administered gliadin antigens, partially mimicking the
effect in humans. Monocyte numbers were significantly increased
in animals sensitised with IFN-c and fed gliadin, which suggests a
response to inflammatory signals that could not be significantly
reduced by B. longum CECT 7347. The data from lymphocyte
phenotyping indicated that gliadin alone reduces CD4+ T cells
and increases CD4+/Foxp3+ T cells, suggesting a regulatory
response in agreement with previous data. Although these
changes were reversed by B. longum CECT 7347 administration,
indicating that the bacterium can induce certain immune
activation in an opposite direction, these effects were not
significant in comparison with controls. Our study also demon-
strated that IFN-c sensitisation, prior to gliadin administration,
was necessary to induce an enteropathy mediated by CD4+ T
cells, while IFN-c sensitisation alone did not cause significant
changes in lymphocyte subpopulations. In the enteropathy
model, the changes in CD4+ T cells were also accompanied by
an increase in CD4+/Foxp3+ (Tregs) cells, which suggests the
development of a counter-regulatory response, as previously
reported [7,11]. The increased Treg cell numbers is concordant
with the increased percentages of circulating regulatory
CD4+CD25+Foxp3+ T cells found in untreated, compared to
treated (gluten-free diet), CD patients [12,13]. In this study,
feeding of B. longum CECT 7347 significantly decreased CD4+
and CD4+/Foxp3 Tregs cells in animals sensitised with IFN-c,
indicating its ability to counteract the Th1-type inflammatory
response triggered by gliadin. However, a recent study has
demonstrated that L. casei ATCC 9595 administration was unable
to significantly modulate CD25+ T cell populations in HLA-DQ8
transgenic mice that had been fed gliadins [27]. B. longum CECT
7347 also induced CD8+ T cells in this model of enteropathy in
agreement with the microbiota-mediated increase in CD8+
lymphocytes previously reported [4]; the role of which in this
disease remains to be determined.
Microbiota composition of animals sensitised with IFN-c and
fed gliadins showed increased gene copy numbers of the
Bacteroides fragilis group in comparison with control animals; these
differences were not associated with gliadin intake and, therefore,
could be due to the induced alterations in intestinal epithelium
architecture and the underlying inflammation in the enteropathy
model [30,31]. This alteration resembles that found in paediatric
CD patients that showed increased bacteroides numbers in faeces
and duodenal biopsies, but not solely associated with the
inflammatory phase of the disease [38,39]. Bifidobacteria and
lactobacilli numbers were not related to gliadin intake or the
induced inflammation, in contrast to human data [38,39]. As
expected, administration of B. longum CECT 7347 led to
increased gene copy numbers of total bifidobacteria in the colon,
which could be responsible for the biological effects detected on
the mucosa and inflammatory markers under gliadin or IFN-c
and gliadin administration. Studies in vitro and in situ have
reported positive effects of different Bifidobacterium strains in the
context of CD, including the reduction of gliadin toxicity [17,40]
and inflammatory potential of gliadin peptides on intestinal cells
[17]. This study has demonstrated the protective effects of B.
longum CECT 7347 against the aberrant gliadin response in vivo,
by reducing inflammatory cytokine production and increasing
regulatory cytokine production (IL-10) in the jejunal mucosa, and
reduced activation of CD4+ T cells. However, the limitations of
the animal model used to fully reproduce the fundamental
features of the disease makes necessary to consider the results
reported with caution and, undoubtedly, studies in humans will
be necessary to really prove beneficial effects of this bacterium on
the disease.
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